Product Program year 2025 Source: CMS Open Payments

Stimulan

Device Bone Void Filler

Open in the dashboard

General payments

$775,519

5,078 payments

Research payments

$0

0 payments

Through program year 2025, $775,519 in general payments and $0 in research payments were reported against Stimulan (Bone Void Filler).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $176,423 1,936
2024 General $137,569 1,314
2023 General $99,544 509
2021 General $107,783 414
2020 General $47,818 214
2019 General $206,382 691

Breakdown

Who paid General payments · program years 2019–2025
  1. Biocomposites Inc $775,519 5,078 payments
Top recipients General payments · program year 2025
  1. Stephen Quinnan Orthopaedic Surgery · West Palm Beach, FL $28,016 16% · 9 payments
  2. Michael Campbell Orthopaedic Surgery · Norfolk, VA $14,346 8% · 6 payments
  3. Adam Sassoon Adult Reconstructive Orthopaedic Surgery · Los Angeles, CA $8,757 5% · 3 payments
  4. Jason Miller Podiatrist, Foot & Ankle Surgery · Malvern, PA $2,415 1% · 3 payments
  5. Matthew Regulski Podiatrist, Foot & Ankle Surgery · Toms River, NJ $2,409 1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $70,937 40% · 374 practitioners
  2. Podiatrist, Foot & Ankle Surgery Podiatrist $26,084 15% · 270 practitioners
  3. Adult Reconstructive Orthopaedic Surgery Orthopaedic Surgery $11,919 7% · 30 practitioners
  4. Podiatrist $8,926 5% · 124 practitioners
  5. Neurological Surgery $8,550 5% · 123 practitioners

The top 5 of 76 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $44,980 25% · 192 recipients
  2. Virginia $17,096 10% · 42 recipients
  3. Pennsylvania $12,991 7% · 134 recipients
  4. California $12,786 7% · 60 recipients
  5. New York $11,921 7% · 153 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,078 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record